Target intelligence / Profile preview

Transmembrane protein 202 (TMEM202)

Target: TMEM202
Molecular classification: Transmembrane protein, Claudin2 superfamily

Overview

Transmembrane protein 202 (TMEM202) is a human protein encoded by the TMEM202 gene, located on chromosome 15q23-q24.1 with six exons. It is a predicted protein-coding gene, part of the Claudin2 superfamily, and is predicted to be located in the plasma membrane. The gene has no reported functional characterization, established biological role, or association with disease or therapeutic targeting in the current literature or clinical databases. There are no known drugs, mechanisms of action, or biomarker roles associated with TMEM202.

Other names: FLJ27523transmembrane protein 202TMEM202

Beyond the preview

Go deeper on Transmembrane protein 202 (TMEM202).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 202 (TMEM202).

Explore the full profile